States Offering Partial GLP-1 Coverage for Obesity Another 22 states, including Texas, Arizona, and Washington, offer partial coverage for obesity-specific GLP-1s
Most clinical guidelines and obesity specialists recommend GLP-1 medications as long-term or indefinite treatments for obesity similar to how blood pressure or cholesterol medications are used chronically
We developed a sensitive, high-throughput, scalable system for profiling the cleavage activity of natural and evolved BoNT proteases on thousands of substrates simultaneously by adapting the genetic circuitry of PACE into a pooled activity-enrichment assay
In conclusion, 3-day EGCG-supplementation decreased postprandial plasma glycerol concentrations, but had no significant effects on skeletal muscle lipolysis and whole-body fat oxidation in overweight individuals
When not seeing patients, she teaches Cell Biology and Anatomy & Physiology at Portland Community College
doi: 10.1016/0006-2952(92)90053-L 158